|
|
||||||||



*
Unité de Pharmacologie Cellulaire, Unité Associée Institut Pasteur/Institut National de la Santé et de la Recherche Médicale, Paris, France;
Department of Cell Biology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands;
Unité dImmunophysiologie et Parasitisme Intracellulaire, Institut Pasteur, Paris, France; and
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Cincinnati, Cincinnati OH 45267
Upon LPS exposure, mononuclear phagocytes produce TNF-
and
IL-10, two cytokines with pro- and anti-inflammatory activities,
respectively. We previously described that murine resident alveolar
macrophages, which play a central role in the immunosurveillance of the
lung alveoli, do not synthesize IL-10 in vivo or in vitro when exposed
to LPS. In the present report we demonstrate that during lung
inflammation induced by the intranasal administration of LPS,
bronchoalveolar cells collected between days 3 and 5 are able to
synthesize IL-10 when exposed to LPS. We also show that depletion of
resident alveolar macrophages by an intratracheal instillation of
liposome-encapsulated clodronate is followed by subsequent
replenishment of the airspaces by mononuclear phagocytes. This is
accompanied by the transient competence of cells for IL-10 production.
The cell capacity to produce IL-10 is evident up to 3 days and then
decreases. This led us to hypothesize that the alveolar environment
contains a down-regulator of LPS-induced IL-10 synthesis by recently
emigrating mononuclear phagocytes. We show that the surfactant protein
A, an airspace protein that has known immunomodulatory activities,
dramatically inhibits LPS-induced IL-10 formation by bone
marrow-derived macrophages. These data show a difference between
resident and inflammatory macrophages with respect to IL-10 synthesis.
Moreover, this study highlights for the first time the inhibitory role
of surfactant protein A in the anti-inflammatory activity of
macrophages through inhibition of IL-10
production.
This article has been cited by other articles:
![]() |
B. Samten, J. C. Townsend, Z. Sever-Chroneos, V. Pasquinelli, P. F. Barnes, and Z. C. Chroneos An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis J. Leukoc. Biol., July 1, 2008; 84(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Balloy, M. Si-Tahar, O. Takeuchi, B. Philippe, M.-A. Nahori, M. Tanguy, M. Huerre, S. Akira, J.-P. Latge, and M. Chignard Involvement of Toll-Like Receptor 2 in Experimental Invasive Pulmonary Aspergillosis Infect. Immun., September 1, 2005; 73(9): 5420 - 5425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashimoto, Y. Asai, and T. Ogawa Treponemal Phospholipids Inhibit Innate Immune Responses Induced by Pathogen-associated Molecular Patterns J. Biol. Chem., November 7, 2003; 278(45): 44205 - 44213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chabot, L. Salez, F. X. McCormack, L. Touqui, and M. Chignard Surfactant Protein A Inhibits Lipopolysaccharide-Induced In Vivo Production of Interleukin-10 by Mononuclear Phagocytes during Lung Inflammation Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hawgood, M. Ochs, A. Jung, J. Akiyama, L. Allen, C. Brown, J. Edmondson, S. Levitt, E. Carlson, A. M. Gillespie, et al. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1002 - L1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guillot, V. Balloy, F. X. McCormack, D. T. Golenbock, M. Chignard, and M. Si-Tahar Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 4 J. Immunol., June 15, 2002; 168(12): 5989 - 5992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |